As the beauty and personal care world sees a growing interest in premium beauty, Johnson & Johnson’s mass-heavy portfolio is holding steady through its power brands Neutrogena, Aveeno and Listerine. While the company is seeing a slowdown in growth,…
In light of Coronavirus, Johnson & Johnson is expected to perform above industry average in 2020, boosted by the successes of its analgesics and cough, cold and allergy remedies brands. While its OTC portfolio is well positioned to see growth at the…